Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Details

Connection

Gareth Morgan to Prosthesis Design

This is a "connection" page, showing publications Gareth Morgan has written about Prosthesis Design.

 
Connection Strength
  
 
 
3.541
  
  1. Zablah JE, Fry R, Ross M, Wilson N, Morgan G. Using in vitro model to assess stent-stent interaction in patients with coronary artery compression. J Interv Cardiol. 2018 Dec; 31(6):870-877.
    View in: PubMed
    Score: 0.563
  2. Husain J, Praichasilchai P, Gilbert Y, Qureshi SA, Morgan GJ. Early European experience with the Venus P-valve?: filling the gap in percutaneous pulmonary valve implantation. EuroIntervention. 2016 Aug 05; 12(5):e643-51.
    View in: PubMed
    Score: 0.482
  3. Morgan GJ. Occlutech? muscular ventricular septal defect device: the first reported human use. Cardiol Young. 2016 Oct; 26(7):1448-51.
    View in: PubMed
    Score: 0.478
  4. Zablah JE, D?hlen G, Ystgaard MB, Morgan GJ. Piggyback mounting for stent and valve deployment during percutaneous pulmonary valve implantation. Catheter Cardiovasc Interv. 2022 10; 100(4):606-611.
    View in: PubMed
    Score: 0.184
  5. Shahanavaz S, Aldoss O, Carr K, Gordon B, Seckeler MD, Hiremath G, Seaman C, Zablah J, Morgan G. Acute and medium term results of balloon expandable stent placement in the transverse arch-a multicenter pediatric interventional cardiology early career society study. Catheter Cardiovasc Interv. 2020 11; 96(6):1277-1286.
    View in: PubMed
    Score: 0.160
  6. Morgan GJ, Sivakumar K, Promphan W, Goreczny S, Prachasilchai P, Qureshi S. Early clinical experience with the straight design of Venus P-valve? in dysfunctional right ventricular outflow tracts. Catheter Cardiovasc Interv. 2020 11; 96(6):E653-E659.
    View in: PubMed
    Score: 0.154
  7. McLennan D, Ivy D, Morgan GJ. Transvenous implantation of the Occlutech Atrial Flow Regulator: Preliminary results from swine models. Congenit Heart Dis. 2019 Sep; 14(5):819-831.
    View in: PubMed
    Score: 0.148
  8. Morgan G, Prachasilchai P, Promphan W, Rosenthal E, Sivakumar K, Kappanayil M, Sakidjan I, Walsh KP, Kenny D, Thomson J, Koneti NR, Awasthy N, Thanopoulos B, Roymanee S, Qureshi S. Medium-term results of percutaneous pulmonary valve implantation using the Venus P-valve: international experience. EuroIntervention. 2019 Jan 20; 14(13):1363-1370.
    View in: PubMed
    Score: 0.143
  9. Morgan GJ, Sadeghi S, Salem MM, Wilson N, Kay J, Rothman A, Galindo A, Martin MH, Gray R, Ross M, Aboulhosn JA, Levi DS. SAPIEN valve for percutaneous transcatheter pulmonary valve replacement without "pre-stenting": A multi-institutional experience. Catheter Cardiovasc Interv. 2019 02 01; 93(2):324-329.
    View in: PubMed
    Score: 0.141
  10. Morgan GJ, Ciuffreda M, Spadoni I, DeGiovanni J. Optimus covered stent: Advanced covered stent technology for complex congenital heart disease. Congenit Heart Dis. 2018 May; 13(3):458-462.
    View in: PubMed
    Score: 0.134
  11. Crystal MA, Morgan GJ, Danon S, Gray RG, Gruenstein DH, Gordon BM, Goldstein BH. Serial Versus Direct Dilation of Small Diameter Stents Results in a More Predictable and Complete Intentional Transcatheter Stent Fracture: A PICES Bench Testing Study. Pediatr Cardiol. 2018 Jan; 39(1):120-128.
    View in: PubMed
    Score: 0.131
  12. Morgan GJ, Kenny D, Duke C, Walsh KP, Qureshi SA. Initial assessment of a novel delivery system (NuDEL? ?) for the covered Cheatham-Platinum stent. Cardiol Young. 2017 Oct; 27(8):1465-1469.
    View in: PubMed
    Score: 0.131
  13. Goreczny S, Qureshi SA, Rosenthal E, Krasemann T, Nassar MS, Anderson DR, Morgan GJ. Comparison of self-expandable and balloon-expanding stents for hybrid ductal stenting in hypoplastic left heart complex. Cardiol Young. 2017 Jul; 27(5):837-845.
    View in: PubMed
    Score: 0.128
  14. Murphy M, Austin C, Bapat V, Morgan GJ. Use of an Edwards Sapien S3 valve to replace a dysfunctional mechanical mitral valve in an 11-year old boy: another small step for surgical and interventional collaboration. Eur J Cardiothorac Surg. 2016 Sep; 50(3):577-9.
    View in: PubMed
    Score: 0.117
  15. Smith B, Thomson J, Crossland D, Spence MS, Morgan GJ. UK multicenter experience using the Gore septal occluder (GSO(TM) ) for atrial septal defect closure in children and adults. Catheter Cardiovasc Interv. 2014 Mar 01; 83(4):581-6.
    View in: PubMed
    Score: 0.100
  16. Morgan G, Lee KJ, Chaturvedi R, Benson L. A biodegradable device (BioSTAR) for atrial septal defect closure in children. Catheter Cardiovasc Interv. 2010 Aug 01; 76(2):241-5.
    View in: PubMed
    Score: 0.079
  17. Griffiths BT, James P, Morgan G, Diamantopoulos A, Durward A, Nyman A. Biodegradable Stents for the Relief of Vascular Bronchial Compression in Children With Left Atrial Enlargement. J Bronchology Interv Pulmonol. 2020 Jul; 27(3):200-204.
    View in: PubMed
    Score: 0.040
  18. Sommer RJ, Love BA, Paolillo JA, Gray RG, Goldstein BH, Morgan GJ, Gillespie MJ. ASSURED clinical study: New GORE? CARDIOFORM ASD occluder for transcatheter closure of atrial septal defect. Catheter Cardiovasc Interv. 2020 06 01; 95(7):1285-1295.
    View in: PubMed
    Score: 0.038
  19. Hiremath G, Morgan G, Kenny D, Batlivala SP, Bartakian S. Balloon expandable covered stents as primary therapy for hemodynamically stable traumatic aortic injuries in children. Catheter Cardiovasc Interv. 2020 02 15; 95(3):477-483.
    View in: PubMed
    Score: 0.038
  20. Danon S, Gray RG, Crystal MA, Morgan G, Gruenstein DH, Goldstein BH, Gordon BM. Expansion Characteristics of Stents Used in Congenital Heart Disease: Serial Dilation Offers Improved Expansion Potential Compared to Direct Dilation: Results from a Pediatric Interventional Cardiology Early Career Society (PICES) Investigation. Congenit Heart Dis. 2016 Dec; 11(6):741-750.
    View in: PubMed
    Score: 0.030
  21. Goreczny S, Morgan GJ, Dryzek P. Live 3D image overlay for arterial duct closure with Amplatzer Duct Occluder II additional size. Cardiol Young. 2016 Mar; 26(3):605-8.
    View in: PubMed
    Score: 0.028
  22. Kang SL, Morgan G, Forsey J, Tometzki A, Martin R. Long-term clinical experience with Amplatzer Ductal Occluder II for closure of the persistent arterial duct in children. Catheter Cardiovasc Interv. 2014 Jun 01; 83(7):1102-8.
    View in: PubMed
    Score: 0.025
  23. Thomson JD, Hildick-Smith D, Clift P, Morgan G, Daniels M, Henderson R, Spence MS, Mahadevan VS, Crossland D, Ormerod O. Patent foramen ovale closure with the Gore septal occluder: initial UK experience. Catheter Cardiovasc Interv. 2014 Feb 15; 83(3):467-73.
    View in: PubMed
    Score: 0.025
  24. Kenny D, Morgan GJ, Bentham JR, Wilson N, Martin R, Tometzki A, Oslizlok P, Walsh KP. Early clinical experience with a modified Amplatzer ductal occluder for transcatheter arterial duct occlusion in infants and small children. Catheter Cardiovasc Interv. 2013 Oct 01; 82(4):534-40.
    View in: PubMed
    Score: 0.024
  25. Forsey J, Kenny D, Morgan G, Hayes A, Turner M, Tometzki A, Martin R. Early clinical experience with the new Amplatzer Ductal Occluder II for closure of the persistent arterial duct. Catheter Cardiovasc Interv. 2009 Oct 01; 74(4):615-23.
    View in: PubMed
    Score: 0.019
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)